SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Myriad Genetics, Inc. (MYGN)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
2355 65 0 MYGN
Emcee:  s myers Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
655Great post, thank you. I hope that management at Myriad will address some of yoscaram(o)uche-3/3/2005
654abstracts up 4-5 weeks before the meeting..... aacr.orgscaram(o)uche-3/3/2005
653<i>This preclinical data will be part of presentations made by Myriad on Mscaram(o)uche-3/3/2005
652J Cell Biol. 2005 Feb 14;168(4):633-42. L1, a novel target of {beta}-catenin sscaram(o)uche-3/3/2005
651I'm going to start making my Yahoo-like posts to this thread. Tuck, do yoscaram(o)uche-3/3/2005
650updated list, MYGN assets: market cap $680M........ 1. Predictive Medicine, prscaram(o)uche-3/3/2005
649>> but the video malfunctioned << for those of you who listened to scaram(o)uche-3/2/2005
648Attended the JMP presentation yesterday....... I like Critchfield, who gave thescaram(o)uche-3/2/2005
647What are the implications of a drug that when injected systematically somehow enZirdu-3/1/2005
646>> An effect of NO, flurbiprofen or synergy? << Exactly the questioscaram(o)uche-3/1/2005
645<<<i>In April, NicOx announced that HCT 1026, a novel NO-donating detnsaf-3/1/2005
644Another drug against beta amyloid deposition and possibly Alzheimers? Courtesy A.J. Mullen-3/1/2005
643Myriad Initiates Phase 1 Trial of MPC-6827 in Metastatic Brain Cancer Tuesday Masim1-3/1/2005
642J Virol. 2005 Mar;79(6):3775-86. The C-Terminal Half of TSG101 Blocks Rous Sarscaram(o)uche-2/27/2005
641<pre>Month Short Interest Percent Change Average Daily Share Volume Daysscaram(o)uche-2/25/2005
640I certainly didn't expect a short "stand" this early or at this mascaram(o)uche-2/25/2005
639>> grind it out capping is done through Archipelago (and one guy who is siscaram(o)uche-2/25/2005
638<i>[0244] Treatment with any CYP2C9 inhibitor within a 2 week period priorscaram(o)uche-2/24/2005
637<i>[0147] Treatment with any CYP2C9 inhibitor within a 2 week period priorscaram(o)uche-2/24/2005
636United States Patent Application 20050042284 Kind Code A1 Hobden, Adrian ; scaram(o)uche-2/24/2005
635ramping up to big-time testing, apoptotic approaches to cancer and autoimmunity.scaram(o)uche-2/24/2005
634Psychopharmacology (Berl). 2005 Feb 22; [Epub ahead of print] Examining SLV-3scaram(o)uche-2/24/2005
633Prolexys Pharmaceuticals Licenses Novel Anti-Cancer Compounds Wednesday Februaryscaram(o)uche-2/23/2005
6328-K...... ITEM 1.01 Entry into a Material Definitive Agreement scaram(o)uche-2/23/2005
6318-K.... ITEM 1.01 Entry into a Material Definitive Agreement On Fescaram(o)uche-2/23/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News